Kusumoto, Shigeru <br/><br/>
Clinical significance of hepatitis B virus (HBV)-DNA monitoring to detect HBV reactivation after systemic chemotherapy.  [electronic resource] 

 -  Journal of clinical oncology : official journal of the American Society of Clinical Oncology  Feb 2011 
 - e100; author reply e101 p.  digital 
<br/><br/> Publication Type: Comment; Letter 
<br/><br/><label>ISSN: </label>1527-7755 
<br/><br/><label>Standard No.: </label>10.1200/JCO.2010.33.0332  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antibodies, Monoclonal, Murine-Derived--adverse effects<br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>Antiviral Agents--therapeutic use<br/>Biomarkers--blood<br/>DNA, Viral--blood<br/>Early Diagnosis<br/>Hepatitis B--diagnosis<br/>Hepatitis B Antibodies--blood<br/>Hepatitis B virus--genetics<br/>Humans<br/>Lymphoma, Large B-Cell, Diffuse--drug therapy<br/>Predictive Value of Tests<br/>Rituximab<br/>Treatment Outcome<br/>Virus Activation